Anika Therapeutics

Anika Therapeutics

Yahoo Finance • 3 days ago

Best Momentum Stocks to Buy for August 26th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 26: BrightSpring Health Services, Inc. BTSG: This home and community-based healthcare services platformhas a Zacks Rank #1 and... Full story

Yahoo Finance • 4 days ago

J&J's Imaavy Gets FDA Approval as the First Treatment for wAIHA

Johnson & Johnson JNJ announced that the FDA has approved Imaavy (nipocalimab-aahu) for the treatment of warm autoimmune hemolytic anemia (wAIHA) in adults and pediatric patients aged 12 years and above who are currently or have been previ... Full story

Yahoo Finance • 21 days ago

Anika (ANIK) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, July 29, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Stephen D. GriffinSenior Vice President, Chief Accounting Officer, and Treasurer - Ian W. McLeodExec... Full story

Yahoo Finance • 25 days ago

Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- American News GroupNews Commentary - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox® created... Full story

Yahoo Finance • 30 days ago

Anika projects 2026 adjusted EBITDA margin of 13% to 17% as it raises revenue growth outlook to 5% to 10%

Earnings Call Insights: Anika Therapeutics (ANIK) Q2 2026 MANAGEMENT VIEW * “The second quarter marked great progress in our efforts to build a stronger, more profitable Anika,” said (President, Principal Financial Officer, CEO & Direc... Full story

Yahoo Finance • 3 months ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced... Full story

Yahoo Finance • 4 months ago

Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary

Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary - Moby Strategic Performance Drivers Commercial channel growth of 12% was driven by the continued momentum of the Integrity platform and strong international OA pain management perfo... Full story

Yahoo Finance • 4 months ago

Anika Reports First Quarter 2026 Financial Results

Grew total company revenue 13%, driven by Commercial Channel strength and favorable OEM Channel order timing Delivered 64% gross margin, +8 points year over year, driven by improved operational execution Operational transformation genera... Full story

Yahoo Finance • 4 months ago

Anika (ANIK) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. Date Wednesday, July 30, 2025 at 8:30 a.m. ET Call participants President and Chief Executive Officer — Cheryl Renee Blanchard, Ph.D. Executive Vice President, Chief Financial Officer and Chief Operating... Full story

Yahoo Finance • 4 months ago

Anika (ANIK) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. Date Thursday, Feb. 26, 2026 at 8:30 a.m. ET Call participants President and Chief Executive Officer — Stephen Griffin Senior Vice President, Chief Accounting Officer and Treasurer — Ian McLeod Need a qu... Full story

Yahoo Finance • 5 months ago

Telix Strengthens Board with Additional Director Appointments

MELBOURNE, Australia and INDIANAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces two additional Non-Executive Director (NED) appointments, effective May 11, 20261, a... Full story

Yahoo Finance • 5 months ago

Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization

By Karen Roman Exec Edge sat down with Nadeem Moiz, Chief Executive Officer at Revance, to learn more about the company’s vision in aesthetics, skincare and therapeutics. Exec Edge: Tell us about Revance and the science-powered products... Full story

Yahoo Finance • 6 months ago

Anika Therapeutics Q4 Earnings Call Highlights

Anika Therapeutics logo Anika Therapeutics (NASDAQ:ANIK) detailed its fourth-quarter and full-year 2025 results and outlined its strategy for 2026 during its earnings call on Thursday, highlighting commercial-channel growth, progress on i... Full story

Yahoo Finance • 6 months ago

Here are the major earnings before the open Thursday

Major earnings expected before the bell on Thursday include: * Viatris (VTRS [https://seekingalpha.com/symbol/VTRS]) * Baidu (BIDU [https://seekingalpha.com/symbol/BIDU]) * Vistance Networks (VISN [https://seekingalpha.com/symbol/VI... Full story

Yahoo Finance • 9 months ago

Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK

NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ:ANIK). The investigation concerns whether the Company a... Full story

Yahoo Finance • 10 months ago

Anika (ANIK) Q3 2025 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Nov. 5, 2025 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Dr. Cheryl Renee Blanchard Executive Vice President, Chief Financial Officer, and Chief Operating Of... Full story

Yahoo Finance • 10 months ago

Anika Reports Third Quarter 2025 Financial Results

Commercial Channel revenue up 22% with continued strong Integrity™ Implant System and Hyalofast® growth, and double-digit International OA Pain Management growth Third and final Hyalofast PMA module filed and data released Cingal® achiev... Full story

Yahoo Finance • 11 months ago

ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika (ANIK) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Anika and would like to discuss... Full story

Yahoo Finance • 11 months ago

Notable Friday Option Activity: SIRI, BTBT, FCX

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in SiriusXM Holdings Inc (Symbol: SIRI), where a total of 13,945 contracts have traded so far, representing approximately 1.4 million... Full story

Yahoo Finance • 11 months ago

ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika (ANIK) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Anika and would like to discuss... Full story